Table 1.
Details of eligible active screening sessions and best estimates of stage 1 and 2 prevalence in the three areas investigated, as well as in all three areas combined (equivalent to treating the three screened populations as one large population)
| Adjumani, Uganda | Arua-Yumbe Uganda | Kiri, South Sudan | Combined | |
|---|---|---|---|---|
| Number of eligible screening sessions | 78 | 64 | 32 | 174 |
| Total population targeted for screening | 76,864 | 163,523 | 11,231 | 251,618 |
| Village population: median (IQR) | 831 (630–1,074) | 2,274 (1,824–2,844) | 217 (103–297) | 1,041 (571–2035) |
| Estimated prevalent cases in stage 1 (S1) | 731 | 298 | 101 | 1130 |
| Estimated prevalent cases in stage 2 (S2) | 363 | 117 | 61 | 541 |
| S 1–S 2 ratio | 2.01 | 2.55 | 1.66 | 2.09 |
IQR inter-quartile range.